Trial intelligence / Profile preview

Plasmin in Acute Peripheral Arterial Occlusion

NCT01222117Phase 2Completed

Sponsor
Grifols
Start
Dec 2010
Primary completion
Dec 2015
Modality
Therapeutic Enzymes
Countries
12
01

Overview

A Phase 2 trial of plasmin in acute peripheral arterial occlusion (APAO), sponsored by Grifols. Started Dec 2010; status: completed.

02

Drugs

plasmin
03

Conditions

acute peripheral arterial occlusion (APAO)

Beyond the preview

Go deeper on NCT01222117.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01222117.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call